Kane Biotech was preparing the annual financial statements and, as part of the year-end procedures, assessed prepared the following alphabetized schedule based on adjusted values at December 31, 2020: (Do not round calculations. Round final answers to nearest whole dollar.) Asset Date of Purchase Deprec. Method Equipment Furniture May 1/15 Jun. 28/15 Units DDB Cost $ 49,000 21,000 Land Apr. 5/15 N/A 94,000 Residual Value $ 2,390 2,900 N/A Useful Life Office building Warehouse Apr. 5/15 Apr. 5/15 SL 95,000 SL 68,500 25,100 19,000 7,900 units 8 yrs N/A 15 yrs 20 yrs Accum. Deprec. $ 28,910 Recoverable Amount $ 5,390 17,339 N/A 31,100 21,938 ODB = Double-declining-balance; SL = Straight-line; Units = Units-of-production; N/A = Not applicable equired: 3,850 110,800 61,500 54,100 Record any impairment losses at December 31, 2020. Assume Kane Biotech has recorded no impairment loss View transaction list View journal entry worksheet No Date General Journal 1 Dec 31, 2020 Impairment loss Debit Cr